| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |